The mechanism responsible for the TNF- inhibitors-induced vitiligo is not fully understood
Ethics declarations Informed consent statement Information regarding this study including the purpose of the study has been disclosed by posting the information disclosure materials approved by the Ethics Committee on the website of the Graduate School of Medicine, Tohoku University, Sendai, Japan
The intensive treatment of the multiple risk factors reduces the development/progression of renal disease18 which is why guidelines insist on comprehensive management of the patient with diabetes (glycemic control and control of cardiovascular risk factors, use of renin-angiotensin system inhibitors, as well as lifestyle changes, including smoking cessation or weight loss in overweight/obese individuals, among others).19 However, the residual renal risk remains very high in optimally treated patients.20 More recently, iSGLT2 has been shown to reduce the risk of cardiovascular and renal events, but still, the residual risk of renal disease progression remains high.21,22 Nevertheless, although the rate of diabetes-related complications (such as myocardial infarction, stroke, lower limb amputations or mortality) have decreased significantly in recent decades, this is not the same for CKD patients requiring renal replacement therapy attributed to diabetic kidney disease (DKD).23 Therefore new treatments are needed that improve glycemic control independently of GFR, with a low risk of hypoglycemia and able to reduce cardiovascular and renal risk in this population
Can genetic testing help personalize my GLP-1 choice between semaglutide and tirzepatide
& Hatton, P
You consume them through your diet and, once digested, they break down into amino acids that can be used to build muscle, hormones and enzymes
